High Prevalence of Proarrhythmic Events in Patients With History of Atrial Fibrillation Undergoing a Rhythm Control Strategy: A Retrospective Study.

Conclusions: Secondary prevention of AF relapses by means of drugs suitable for accomplishing rhythm control strategy exposes the patients to incumbent risk of proarrhythmic events. Thus, the choice to avoid some varieties of antiarrhythmics with marked proarrhythmic potential (class IC drugs, sotalol, quinidine) appears to be warranted. PMID: 31019629 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/31019629?dopt=Abstract

Source: Clin Med Res - April 27, 2019 Category: Research Authors: De Vecchis R, Di Maio M, Noutsias M, Rigopoulos AG, Ariano C, Di Biase G Tags: J Clin Med Res Source Type: research